Celanese Corporation (CE) 股票分析

公司概述

Celanese Corporation engages in the global production and distribution of engineered polymers, operating primarily through its Engineered Materials and Acetyl Chain business segments. This positioning places the firm firmly within the Basic Materials sector, specifically the Chemicals industry, where it focuses on supplying specialized materials for various industrial applications. The company commands a market capitalization of $6.97B and generates annual revenue of $9.54B, supported by a workforce of 11,434 employees. These financial scales indicate that Celanese maintains a significant footprint in the chemical supply chain, yet the negative net income suggests current profitability challenges despite substantial operational revenue generation.

财务健康

The company reported a revenue of $9.54B over the trailing twelve months, yet recorded a net income of -$1.144B alongside an EBITDA of $1.56B. The substantial gap between the positive EBITDA and the deeply negative net income reveals a cost structure heavily impacted by interest expenses and other non-operating charges that erode bottom-line profitability. Despite the net loss, the entity maintains a free cash flow of $368.62M, which provides a degree of financial flexibility to cover operational obligations and potentially fund strategic initiatives. The gross margin stands at 20.6%, while the operating margin is 8.6%, and the profit margin is -12.2%, indicating that operating costs and non-operating expenses are significantly compressing overall profitability. On the balance sheet, Celanese holds $1.26B in cash against $12.93B in total debt, resulting in a debt-to-equity ratio of 289.22, which characterizes a highly leveraged financial position. The current ratio of 1.55 suggests that the company possesses adequate short-term liquidity to meet its immediate obligations with a cushion of 1.55 times current liabilities. Furthermore, the return on equity is -22.5% and the return on assets is 2.3%, metrics that collectively reveal management effectiveness is currently hindered by significant losses relative to the equity base and asset utilization.

估值评估

Celanese's valuation metrics show a trailing P/E ratio of N/A due to recent losses, while the forward P/E is 9.98, implying that the market prices in a significant expected recovery in earnings trajectory. The price-to-book ratio is 1.69, indicating that the market values the company at a premium of 69% over its tangible book value. Alternative valuation multiples such as the price-to-sales ratio of 0.73 and an EV/EBITDA of 12.11 suggest that investors are focusing on revenue quality and cash generation potential rather than current earnings power. Regarding price momentum, the stock has traded between a 52-week low of $35.13 and a high of $67.82. Assuming a current price context within this range, the valuation reflects a recovery from the 52-week low but remains below the previous cycle peak, highlighting the volatility experienced over the last year. The beta value of 0.85 indicates that the stock exhibits lower price volatility relative to the broader market, moving with less intensity than the general equity benchmark.

Growth & Income

Celanese experienced a revenue growth rate of -6.5% year-over-year, while earnings growth is currently N/A due to the reported losses, meaning earnings are not growing and are contracting alongside revenue. The company pays a dividend with a yield of 0.2% and maintains a payout ratio of 27.9%, a level that appears sustainable only if earnings stabilize, as the current negative net income technically makes the payout mathematically unsupported by core operations. Given the negative net income, the dividend payout ratio technically exceeds the company's ability to fund it from current earnings, relying instead on free cash flow or reserves. Overall, the growth and income profile is characterized by revenue contraction, negative earnings, and a low-yield dividend that requires careful monitoring of the turnaround in profitability to ensure sustainability.